Genomic and Epigenomic Biomarkers of Toxicology an d Disease: Clinical and Therapeutic Actions

The latest developments in biomarker research applicable to toxicology and medicine are covered in Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions, a comprehensive and authoritative compilation of up-to-date developments. This edited volume offers unique insights into current trends and future directions of research in the discussed areas, with contributions from a collection of internationally recognized investigators.

Format: Hardback
Length: 512 pages
Publication date: 19 May 2022
Publisher: John Wiley and Sons Ltd

The field of biomarker research, particularly in the domains of toxicology and medicine, is experiencing a rapid surge of advancements, driven by cutting-edge studies scattered across the academic literature. This rapid development has made it challenging to ascertain the current status of ongoing scientific activity in this area. Genomic and epigenomic biomarkers, which provide valuable insights into the genetic and epigenetic mechanisms underlying various diseases and toxicological processes, are emerging as key tools in clinical and therapeutic applications.

In response to this need, "Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions" has been published. This comprehensive and authoritative compilation offers a timely overview of the latest developments in the application of genomic and epigenomic biomarkers to toxicology, disease prevention, cancer detection, therapeutics, gene therapy, and other fields.

Edited by a team of internationally recognized investigators, this edited volume provides unique insights into current trends and future directions of research in these areas. The book combines state-of-the-art information on genomic and epigenomic biomarkers from a diverse range of specialists from around the world.

The monograph encompasses a wide range of topics, including:

A thorough introduction to microRNAs as non-invasive biomarkers of toxicity and chemical hazard.
Comprehensive explorations of extracellular vesicle-associated miRNAs as toxic biomarkers, as well as transcriptomic applications in toxicology and medicine.
Practical discussions of circulating miRNAs as biomarkers of metal exposure, as well as microRNAs biomarkers of malignant mesothelioma.
In-depth examinations of the role of noncoding RNAs in innate immune responses perturbed by environmental arsenic, with a focus on microRNAs.

This monograph is an invaluable resource for researchers, toxicologists, risk assessors, and regulators. It will also serve as a valuable reference for students and practitioners in the fields of medicine, toxicology, and genetics.

The rapid advancements in biomarker research have the potential to transform the way we diagnose, treat, and prevent diseases. By leveraging the power of genomic and epigenomic biomarkers, we can gain a deeper understanding of the underlying mechanisms of disease and develop more targeted and effective therapies.

However, there are also challenges associated with the use of biomarkers, such as the need for standardization, validation, and interpretation. Additionally, ethical considerations must be taken into account when collecting and analyzing personal data.

As the field of biomarker research continues to evolve, it is important to invest in research and development to improve the accuracy, reliability, and interpretability of biomarkers. This will enable us to make more informed decisions about healthcare and disease prevention and ultimately improve the quality of life for individuals around the world.

In conclusion, the latest developments in biomarker research applicable to toxicology and medicine are presenting exciting opportunities for breakthroughs in clinical and therapeutic applications. "Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions" is a valuable resource that provides a comprehensive and authoritative compilation of up-to-date developments in this field. By leveraging the power of genomic and epigenomic biomarkers, we can gain a deeper understanding of the underlying mechanisms of disease and develop more effective therapies to improve the health and well-being of individuals worldwide.

Weight: 1218g
Dimension: 184 x 260 x 33 (mm)
ISBN-13: 9781119807674